These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 31846839

  • 1. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M, Liu H, Sun K, Liu J, Mou Y, Qi D, Zhou C, Abudunaibi M, Tasiken B, Li J, Cheng H, Huang H.
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [Abstract] [Full Text] [Related]

  • 2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 3. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 4. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M, Shan J, Xu H, Xia G, Xu Q, Quan K, Liu X, Dai M.
    J Ethnopharmacol; 2021 Aug 10; 276():114176. PubMed ID: 33933570
    [Abstract] [Full Text] [Related]

  • 5. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G, Xu Q, Dai M, Liu X.
    Biochem Biophys Res Commun; 2019 Feb 05; 509(2):329-334. PubMed ID: 30579598
    [Abstract] [Full Text] [Related]

  • 6. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL, Xu RS, Jiang DL, He XL, Su Q, Jin C, Li X.
    Bone; 2015 Jun 05; 75():128-37. PubMed ID: 25708053
    [Abstract] [Full Text] [Related]

  • 7. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
    Chen X, Zhi X, Pan P, Cui J, Cao L, Weng W, Zhou Q, Wang L, Zhai X, Zhao Q, Hu H, Huang B, Su J.
    FASEB J; 2017 Nov 05; 31(11):4855-4865. PubMed ID: 28739641
    [Abstract] [Full Text] [Related]

  • 8. Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.
    Li DZ, Zhang QX, Dong XX, Li HD, Ma X.
    J Bone Miner Metab; 2014 Sep 05; 32(5):494-504. PubMed ID: 24196871
    [Abstract] [Full Text] [Related]

  • 9. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J, Jing Z, Hu W, Yu J, Cui X.
    Med Sci Monit; 2017 Oct 24; 23():5056-5069. PubMed ID: 29061958
    [Abstract] [Full Text] [Related]

  • 10. Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway.
    Kim HJ, Park C, Kim GY, Park EK, Jeon YJ, Kim S, Hwang HJ, Choi YH.
    Biosci Trends; 2018 Oct 24; 12(3):257-265. PubMed ID: 30012915
    [Abstract] [Full Text] [Related]

  • 11. Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
    Lu J, Ye C, Huang Y, Huang D, Tang L, Hou W, Kuang Z, Chen Y, Xiao S, Yishake M, He R.
    J Cell Mol Med; 2020 Sep 24; 24(18):10444-10457. PubMed ID: 32681612
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.
    Immunol Lett; 2014 Sep 24; 161(1):31-7. PubMed ID: 24792671
    [Abstract] [Full Text] [Related]

  • 13. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
    Liu C, Guan H, Cai C, Li F, Xiao J.
    Exp Cell Res; 2017 Mar 15; 352(2):293-303. PubMed ID: 28209487
    [Abstract] [Full Text] [Related]

  • 14. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE, Lee J, Seo DH, In Lee H, Ri Park D, Lee GR, Jo YJ, Kim N, Kwon M, Shon H, Kyoung Seo E, Kim HS, Young Lee S, Jeong W.
    Free Radic Biol Med; 2017 Nov 15; 112():191-199. PubMed ID: 28774817
    [Abstract] [Full Text] [Related]

  • 15. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
    Lee SY, Lee KS, Yi SH, Kook SH, Lee JC.
    PLoS One; 2013 Nov 15; 8(12):e80873. PubMed ID: 24324641
    [Abstract] [Full Text] [Related]

  • 16. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X, Li X, Zhai X, Zhi X, Cao L, Qin L, Su J.
    Cell Physiol Biochem; 2018 Nov 15; 51(6):2858-2871. PubMed ID: 30562759
    [Abstract] [Full Text] [Related]

  • 17. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
    Liou SF, Hsu JH, Lin IL, Ho ML, Hsu PC, Chen LW, Chen IJ, Yeh JL.
    PLoS One; 2013 Nov 15; 8(7):e69468. PubMed ID: 23936022
    [Abstract] [Full Text] [Related]

  • 18. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Chen D, Ye Z, Wang C, Wang Q, Wang H, Kuek V, Wang Z, Qiu H, Yuan J, Kenny J, Yang F, He J, Liu Y, Wang G, Zhang M, Zhang G, Wang J, Chen P, Xu J.
    Pharmacol Res; 2020 Sep 15; 159():104944. PubMed ID: 32454224
    [Abstract] [Full Text] [Related]

  • 19. Ecklonia cava Extract Containing Dieckol Suppresses RANKL-Induced Osteoclastogenesis via MAP Kinase/NF-κB Pathway Inhibition and Heme Oxygenase-1 Induction.
    Kim S, Kang SS, Choi SI, Kim GH, Imm JY.
    J Microbiol Biotechnol; 2019 Jan 28; 29(1):11-20. PubMed ID: 30518021
    [Abstract] [Full Text] [Related]

  • 20. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss.
    Shi L, Ren L, Li J, Liu X, Lu J, Jia L, Xie B, Tang S, Liu W, Zhang J.
    Chin J Nat Med; 2024 Mar 28; 22(3):212-223. PubMed ID: 38553189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.